Delivery Order SPE2DB20D3103-SPE2DB25FP9J0
- Not listed
- The Defense Logistics Agency (DLA) awarded a $5,155.59 delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Imitrex 6 mg/0.5 mL cartridges (0.5 mL units). This firm fixed-price contract represents a non-competitive delivery order with an ultimate completion date of August 11, 2025, and will be performed at the company's corporate office in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Imitrex 6 mg/0.5 ml cartridges valued at $20,917.11. This firm fixed-price delivery order is scheduled for completion by August 5, 2025, and will be fulfilled from the contractor's location in Conshohocken, Pennsylvania. The award utilized no set-aside designation, indicating it was competitively awarded through open competition. This delivery order is executed as a child...
- The Defense Logistics Agency awarded a delivery order valued at $12,487.60 to AmerisourceBergen Drug Corp for Imitrex 6 mg/0.5 ml cartridges on July 22, 2025, with completion targeted for July 23, 2025. This firm fixed-price contract represents a non-set-aside award and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Imitrex is a migraine treatment medication, and this delivery order fulfills specific pharmaceutical supply needs for federal healthcare...
- The Defense Logistics Agency awarded a delivery order valued at $6,600.81 to AmerisourceBergen Drug Corp for the supply of Imitrex 6 mg/0.5 mL cartridges on July 30, 2025, with an ultimate completion date of July 31, 2025. This firm fixed-price contract, which carries no set-aside designation, represents a competitive award for pharmaceutical supplies to be delivered to the Conshohocken, Pennsylvania location. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- This is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Imitrex 6 mg/0.5 ml cartridges. The contract has a firm fixed price of $12,124.38 and a completion date of March 7, 2025. The award is not designated as a set-aside contract. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 with the DLA Troop Support Medical, which serves as the primary vehicle for...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a for-profit pharmaceutical distribution company, to provide 4,564,171,029 units of Imitrex 6 mg/0.5 ml cartridges. The delivery order contract has a firm fixed price of $12,332.63 and a period of performance through April 5, 2024. There is no set-aside designation associated with this award. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency (DLA) awarded a $5,036.17 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp to provide 4,564,220,914 units of Imitrex 6 mg/0.5 ml cartridges. This contract has an ultimate completion date of April 10, 2024 and was not set aside for any specific business category. AmerisourceBergen, a for-profit pharmaceutical distributor, is a key vendor for federal healthcare programs, particularly supporting military and veterans' medical needs through major...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type, valued at $9,657.51. It is for the delivery of Imitrex 6 mg/0.5 ml cartridges to a location in Conshohocken, Pennsylvania, with a completion date of June 17, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,062.66 firm fixed-price contract is for the supply of Imitrex 6 mg/0.5 ml cartridges to support U.S. government medical requirements. The contract has an ultimate completion date of November 6, 2024 and was awarded on November 5, 2022. There is no set-aside designation noted for this award. Amerisourcebergen...
- This is a $1,516.35 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract covers the supply of IMITREX 6 MG/0.5 ML CARTRIDGES 0.5ML, a specialty medication, to support military healthcare programs. The contract has an ultimate completion date of January 13, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB25FP9J0Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,107.71 to AmerisourceBergen Drug Corp for the supply of Imitrex 6 mg/0.5 mL cartridges on August 18, 2025, with a completion date of August 19, 2025. This firm fixed price delivery order represents a continuation of pharmaceutical supply support to federal medical procurement needs, specifically supporting military and veteran healthcare systems. The award was made through open competition with no set-aside designation, reflecting AmerisourceBergen's established capability to meet federal procurement requirements. This delivery order operates under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of medications, vaccines, and medical supplies to support military healthcare programs worldwide. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, functions as a critical pharmaceutical distributor and healthcare solutions provider for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems, with the company demonstrating significant experience delivering specialized medical commodities across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.1k | 8/18/25 |